2009
DOI: 10.1007/s00535-009-0004-3
|View full text |Cite
|
Sign up to set email alerts
|

Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide

Abstract: Combination chemotherapy with CE may be effective for the treatment of SCC of the pancreas; EUS-FNA plays an important role in distinguishing SCC from other pancreatic malignancies, leading to the appropriate treatment being given.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 27 publications
(46 reference statements)
1
7
0
Order By: Relevance
“…They used a schedule consisting of etoposide and cisplatin which made the patient remain in complete remission 50 months after the diagnosis. Sakamoto et al [19] diagnosed 4 cases of SCCP with endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA). All patients were treated with combination chemotherapy using a schedule consisting of carboplatin and etoposide.…”
Section: Discussionmentioning
confidence: 99%
“…They used a schedule consisting of etoposide and cisplatin which made the patient remain in complete remission 50 months after the diagnosis. Sakamoto et al [19] diagnosed 4 cases of SCCP with endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA). All patients were treated with combination chemotherapy using a schedule consisting of carboplatin and etoposide.…”
Section: Discussionmentioning
confidence: 99%
“…These complications have led to the development of an anterior approach under the guidance of transcutaneous US, CT or EUS [17,18,19,20]. However, they can be avoided through the use of EUS, which allows direct access to the CP and real-time imaging of the celiac space for CPN as well as fine needle aspiration for diagnostic purposes and tumor staging [21,22]. Thus, since it was first reported by Wiersema and Wiersema [23 ]in 1996, EUS-CPN is now a widely practiced alternative approach.…”
Section: Eus-guided Celiac Plexus Neurolysismentioning
confidence: 99%
“…small tumors that are only depicted by EUS [8] . EUS is superior to all other imaging modalities for the detection of small pancreatic cancers [9][10][11][12] .…”
mentioning
confidence: 99%